Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

SmartAce (99.71) Submitted: 4/24/2013 1:56:25 PM : Start Price: $1.79 ACUR Score: -16.16

Socialism is a philosophy of failure, the creed of ignorance, and the gospel of envy, its inherent virtue is the equal sharing of misery.
Winston Churchill

zzlangerhans (99.78) Submitted: 2/11/2013 5:36:12 AM : Start Price: $2.13 ACUR Score: -2.24

Acura seems like a fairly safe downthumb to me on an upswing. Once again, we're looking at two potential revenue streams. The company should be reporting their first quarter of Oxecta royalty revenue in May. I haven't heard a peep about Oxecta sales from Pfizer, but I'm guessing they are less than blockbuster since Pfizer returned the rights to future drugs using the same technology. And then there's Nexafed, the tamper-resistant pseudoephedrine no one asked for. I'm not feeling an enterprise value of a million here, let alone 75 million.

RXDOC73 (99.22) Submitted: 7/31/2012 8:11:42 AM : Start Price: $2.00 ACUR Score: -0.86

Buy out target at this low price!

maniacdog (< 20) Submitted: 3/2/2012 8:30:51 AM : Start Price: $3.17 ACUR Score: -45.27

It does not matter whether their oxycodone drug Onexa cuts abuse or not doctors are under such pressure when they prescribe oxy they will prescribe this new pill just to keep in the good graces of the DEA. Of course this drug will not curb abuse always a way around it, but if somebody wants pain meds Onexa will become the norm whether it works or not.

Lcrazylegs84 (< 20) Submitted: 10/1/2011 1:06:09 AM : Start Price: $3.50 ACUR Score: -79.24

going up

thebigpicture37 (< 20) Submitted: 6/22/2011 11:47:13 AM : Start Price: $3.97 ACUR Score: -67.92

The 20 million royalty will be paid to Acura Pharma in late June or early July. Also Pfizer plans to partner with Acura on other opioid drugs using the Aversion TM technology. However my favorite is an OTC product with pseudoephedrine which will be rolled out later this year. Nexafed TM using Impede TM technology. This drug will have the same ingredients as Sudafed TM and brand name.

KimLanners (< 20) Submitted: 6/20/2011 10:53:32 AM : Start Price: $4.98 ACUR Score: -82.14

fda approval

pyupie0216 (22.42) Submitted: 8/18/2010 5:55:20 PM : Start Price: $2.44 ACUR Score: +55.88

screen

steelersnextat7 (< 20) Submitted: 9/22/2009 2:10:56 AM : Start Price: $4.88 ACUR Score: -105.81

FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up

manvsmonkey (78.71) Submitted: 7/28/2008 2:09:10 PM : Start Price: $7.30 ACUR Score: -104.85

seems like the phase III trial is going well

http://seekingalpha.com/article/87373-a-biotech-bloom-in-july?source=side_bar_long_ideas

davidr825 (< 20) Submitted: 6/13/2008 7:58:39 PM : Start Price: $9.54 ACUR Score: -100.93

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical